FOSTER CITY, Calif.--(BUSINESS WIRE)--Feb. 6, 2018--
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the company’s
Board of Directors has declared an increase of 10% in the company’s
quarterly cash dividend, beginning in the first quarter of 2018. The
dividend increase will result in a quarterly dividend of $0.57 per share
of common stock. The dividend is payable on March 29, 2018, to
stockholders of record at the close of business on March 16, 2018.
Future dividends will be subject to Board approval.
About Gilead
Gilead Sciences is a biopharmaceutical company that discovers, develops
and commercializes innovative therapeutics in areas of unmet medical
need. The company’s mission is to advance the care of patients suffering
from life-threatening diseases. Gilead has operations in more than 35
countries worldwide, with headquarters in Foster City, California.
For more information on Gilead Sciences, please visit the company’s
website at www.gilead.com,
follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs
at 1-800-GILEAD-5 or 1-650-574-3000.
View source version on businesswire.com: http://www.businesswire.com/news/home/20180206005928/en/
Source: Gilead Sciences, Inc.
Gilead Sciences, Inc.InvestorsRobin
Washington, 650-522-5688Sung Lee, 650-524-7792
